Clinical Trial Update: Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.) [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 open-label trial evaluating anecortave acetate 15 mg for Coat's disease (Coats' disease). The study was conducte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coats Disease

Drugs mentioned

• anecortave acetate (anecortave acetate)

Snippet

Sponsor: Manhattan Eye, Ear & Throat Hospital | Conditions: Coat's Disease | Phase 2 | Status: COMPLETED